New Zealand markets closed

Roivant Sciences Ltd. (ROIV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.80+0.06 (+0.56%)
At close: 04:00PM EDT
11.04 +0.24 (+2.22%)
After hours: 07:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.98B
Enterprise value 1.94B
Trailing P/E 2.07
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)71.92
Price/book (mrq)1.34
Enterprise value/revenue 15.56
Enterprise value/EBITDA 0.45

Trading information

Stock price history

Beta (5Y monthly) 1.24
52-week change 3-9.85%
S&P500 52-week change 318.96%
52-week high 313.24
52-week low 38.24
50-day moving average 310.89
200-day moving average 310.54

Share statistics

Avg vol (3-month) 34.89M
Avg vol (10-day) 34.38M
Shares outstanding 5738.72M
Implied shares outstanding 6746.77M
Float 8354.48M
% held by insiders 122.39%
% held by institutions 172.57%
Shares short (15 Jul 2024) 440.85M
Short ratio (15 Jul 2024) 46.71
Short % of float (15 Jul 2024) 411.26%
Short % of shares outstanding (15 Jul 2024) 45.53%
Shares short (prior month 14 Jun 2024) 440.07M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3,484.86%
Operating margin (ttm)-919.46%

Management effectiveness

Return on assets (ttm)-14.04%
Return on equity (ttm)105.04%

Income statement

Revenue (ttm)124.8M
Revenue per share (ttm)0.16
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -1.06B
Net income avi to common (ttm)4.35B
Diluted EPS (ttm)5.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.54B
Total cash per share (mrq)8.85
Total debt (mrq)499.75M
Total debt/equity (mrq)7.75%
Current ratio (mrq)25.24
Book value per share (mrq)7.40

Cash flow statement

Operating cash flow (ttm)-765.27M
Levered free cash flow (ttm)-525.94M